UP Govt Unveils 9.5 Crore Plan With 20 Institutions For Pharma Growth
The Uttar Pradesh government has introduced its first-ever standard operating procedure (SOP) for the pharmaceutical sector, aiming to strengthen drug manufacturing and clinical research. This initiative is designed to position the state as a global pharma hub by streamlining production and clinical trial processes.
As part of the plan, 20 medical institutions across the state have been onboarded to conduct clinical trials. These institutions will follow globally aligned protocols and receive specialised training to ensure adherence to the best practices. A budget of ₹9.5 crore has been allocated to create a robust ecosystem for pharmaceutical innovation and testing.
The strategy also includes hosting conferences with experts, standardising resources for pharmaceutical counselling, and conducting Good Clinical Practices (GCP) training for doctors and researchers in selected colleges. Partnerships with prominent institutions such as THSTI, AKTU, and BIRAC will further enhance the sector’s capabilities.
This landmark move is expected to unlock new opportunities and address challenges faced by the state’s pharma industry.
2026-07-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
DKSH to Distribute Exsymol's Silanols, Peptides, and Natural Active Ingredients in South Korea
-
Venator Launches TMP- and TME-Free Titanium Dioxide
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
Hengli Sanctions Spill Over: One Barrel of Iranian Crude Pulls an Aromatics Chain Into Risk
-
Chemicals Are Going Wild: Sulfur Surges 512%, Titanium Dioxide, Polyols and Sulfuric Acid Lose Control
-
Global Chemical Inventories Hit Critical Lows as Over 200 Chinese Companies Suspend Quotations
Recommend Reading
-
EFSA Deems Extended Use of Bacillolysin Enzyme Safe
-
EFSA Publishes Peer Review on Fungicide Prothioconazole
-
Polystyrene Margins Collapse: From ¥490 Profit to ¥550 Loss – Who Ate the PS Profit?
-
ABS Market “Too Hurt”: Prices Fall Below Key Threshold Before September
-
PC Industry Faces Overcapacity – Breakthrough via High-End Focus
-
Raw Materials Soften, Consumption Sluggish—PC Prices Fall from High Levels
-
Market Support Weakens, Acetic Acid Prices Continuously Decline
-
In August, China's propylene oxide market showed a trend of first declining then rising
-
Premium Global Chemical Sourcing Requests (20-22Apr, 2026)
-
Supply and Demand Costs Resonate, Polyethylene Weakens in Short-term Fluctuations